1. Home
  2. CALC vs TOPS Comparison

CALC vs TOPS Comparison

Compare CALC & TOPS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • CALC
  • TOPS
  • Stock Information
  • Founded
  • CALC 2011
  • TOPS 2000
  • Country
  • CALC United States
  • TOPS Greece
  • Employees
  • CALC N/A
  • TOPS N/A
  • Industry
  • CALC Biotechnology: Pharmaceutical Preparations
  • TOPS Marine Transportation
  • Sector
  • CALC Health Care
  • TOPS Consumer Discretionary
  • Exchange
  • CALC Nasdaq
  • TOPS Nasdaq
  • Market Cap
  • CALC 32.4M
  • TOPS 27.2M
  • IPO Year
  • CALC N/A
  • TOPS 2004
  • Fundamental
  • Price
  • CALC $3.80
  • TOPS $6.25
  • Analyst Decision
  • CALC Strong Buy
  • TOPS
  • Analyst Count
  • CALC 2
  • TOPS 0
  • Target Price
  • CALC $14.50
  • TOPS N/A
  • AVG Volume (30 Days)
  • CALC 133.2K
  • TOPS 20.2K
  • Earning Date
  • CALC 08-11-2025
  • TOPS 08-08-2025
  • Dividend Yield
  • CALC N/A
  • TOPS N/A
  • EPS Growth
  • CALC N/A
  • TOPS N/A
  • EPS
  • CALC N/A
  • TOPS 1.09
  • Revenue
  • CALC N/A
  • TOPS $86,127,000.00
  • Revenue This Year
  • CALC N/A
  • TOPS $9.90
  • Revenue Next Year
  • CALC N/A
  • TOPS N/A
  • P/E Ratio
  • CALC N/A
  • TOPS $5.74
  • Revenue Growth
  • CALC N/A
  • TOPS 3.83
  • 52 Week Low
  • CALC $1.42
  • TOPS $5.00
  • 52 Week High
  • CALC $5.97
  • TOPS $11.47
  • Technical
  • Relative Strength Index (RSI)
  • CALC 73.90
  • TOPS 52.30
  • Support Level
  • CALC $3.37
  • TOPS $5.86
  • Resistance Level
  • CALC $4.26
  • TOPS $6.49
  • Average True Range (ATR)
  • CALC 0.41
  • TOPS 0.34
  • MACD
  • CALC 0.21
  • TOPS 0.04
  • Stochastic Oscillator
  • CALC 82.80
  • TOPS 62.96

About CALC CalciMedica Inc.

CalciMedica Inc is a clinical-stage biopharmaceutical company focused on developing therapeutics that treat serious illnesses driven by inflammatory and immunologic processes and direct cellular damage. Its product candidates act upon calcium release-activated calcium (CRAC) channels and would constitute a new class of drugs. Its product candidate is Auxora, a potent and selective intravenous formulated small molecule CRAC channel inhibitor containing the active compound zegocractin (formerly referred to as CM4620) that, in animal models, reduced acute epithelial and/or endothelial cell injury and inflammation in organs, such as the pancreas, lungs and kidneys.

About TOPS TOP Ships Inc.

TOP Ships Inc owns tanker vessels throughout the world. The Company is an international owner and operator of modern, fuel-efficient eco tanker vessels focusing on the transportation of crude oil, petroleum products (clean and dirty), and bulk liquid chemicals. It generates revenue from the Time Charter agreements.

Share on Social Networks: